Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M4 muscarinic acetylcholine receptor agonists
作者:Atsushi Suwa、Yasuko Konishi、Yoshiharu Uruno、Kentaro Takai、Tomokazu Nakako、Mutsuko Sakai、Takeshi Enomoto、Yoshiaki Ochi、Harumi Matsuda、Atsushi Kitamura、Yasuaki Uematsu、Akihiko Kiyoshi、Takaaki Sumiyoshi
DOI:10.1016/j.bmcl.2014.04.083
日期:2014.7
designed and synthesized novel N-sulfonyl-7-azaindoline derivatives as selective M4 muscarinic acetylcholine receptor agonists. Modification of the N-carbethoxy piperidine moiety of compound 2, an M4 muscarinic acetylcholine receptor (mAChR)-preferring agonist, led to compound 1, a selective M4 mAChR agonist. Compound 1 showed a highly selective M4 mAChR agonistic activity with weak hERG inhibition in
我们设计和合成了新型的N-磺酰基-7-氮杂二氢吲哚衍生物,作为选择性的M 4毒蕈碱乙酰胆碱受体激动剂。化合物2(一种M 4毒蕈碱乙酰胆碱受体(mAChR)偏爱的激动剂)的N-甲乙氧基哌啶部分的修饰导致了化合物1(一种选择性的M 4 mAChR激动剂)。化合物1显示出高度选择性的M 4 mAChR激动活性,体外hERG抑制作用较弱。体内化合物1的药代动力学研究表明,大鼠具有良好的生物利用度和脑渗透性。化合物1 逆转了甲基苯丙胺诱导的大鼠运动过度活跃(1-10 mg / kg,口服)。